NCT02015156 - A Study Evaluating The Safety Of PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-06) | Biotech Hunter

Enrollment

162

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 28, 2014

Study Completion Date

April 30, 2014

Conditions

Healthy

Interventions

BIOLOGICAL

PF-05280014

Concentrate for solution for infusion, sterile vial 150 mg, single-dose 6 mg/kg administered as 90-minute infusion on Day 1

BIOLOGICAL

Herceptin®

Concentrate for solution for infusion, sterile vial 440 mg, single-dose 6 mg/kg administered as 90-minute infusion on Day 1

Trial Locations (2)

Pfizer Investigational Site, Overland Park

Pfizer Investigational Site, Overland Park